Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novanta (NOVT) Share-based Compensation: 2010-2025

Historic Share-based Compensation for Novanta (NOVT) over the last 16 years, with Sep 2025 value amounting to $6.7 million.

  • Novanta's Share-based Compensation rose 5.25% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.9 million, marking a year-over-year increase of 0.19%. This contributed to the annual value of $23.3 million for FY2024, which is 8.91% down from last year.
  • Latest data reveals that Novanta reported Share-based Compensation of $6.7 million as of Q3 2025, which was down 10.67% from $7.5 million recorded in Q2 2025.
  • Over the past 5 years, Novanta's Share-based Compensation peaked at $8.5 million during Q4 2021, and registered a low of $4.6 million during Q4 2024.
  • For the 3-year period, Novanta's Share-based Compensation averaged around $6.4 million, with its median value being $6.4 million (2024).
  • Its Share-based Compensation has fluctuated over the past 5 years, first surged by 107.69% in 2021, then tumbled by 35.71% in 2024.
  • Novanta's Share-based Compensation (Quarterly) stood at $5.4 million in 2021, then declined by 2.54% to $5.3 million in 2022, then surged by 36.06% to $7.2 million in 2023, then plummeted by 35.71% to $4.6 million in 2024, then increased by 5.25% to $6.7 million in 2025.
  • Its Share-based Compensation stands at $6.7 million for Q3 2025, versus $7.5 million for Q2 2025 and $7.1 million for Q1 2025.